ERASCA INC's ticker is and the CUSIP is 29479A108. A total of 56 filers reported holding ERASCA INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $819,731 | -75.1% | 416,107 | -65.0% | 0.00% | -100.0% |
| Q2 2023 | $3,285,879 | +67510.7% | 1,190,536 | -26.3% | 0.00% | -33.3% |
| Q1 2023 | $4,860 | +244.7% | 1,614,512 | +393.7% | 0.00% | +200.0% |
| Q4 2022 | $1,410 | -99.9% | 327,038 | -9.3% | 0.00% | -50.0% |
| Q3 2022 | $2,812,000 | +543.5% | 360,473 | +1650.7% | 0.00% | – |
| Q3 2021 | $437,000 | – | 20,590 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 11,055,554 | $47,649,438 | 12.20% |
| EDBI Pte Ltd | 888,888 | $3,831,107 | 4.88% |
| Cormorant Asset Management, LP | 10,813,246 | $46,605 | 3.12% |
| AH Equity Partners LSV II, L.L.C. | 312,500 | $1,346,875 | 1.64% |
| GREAT POINT PARTNERS LLC | 1,538,461 | $6,630,767 | 1.30% |
| Artal Group S.A. | 4,710,682 | $20,303 | 1.13% |
| PFM Health Sciences, LP | 4,797,460 | $20,677,053 | 0.74% |
| Ghisallo Capital Management LLC | 929,316 | $4,005,352 | 0.71% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 462,972 | $1,995,409 | 0.38% |
| CVI Holdings, LLC | 376,716 | $1,623,646 | 0.21% |